Systematic biopsy | Targeted biopsy | |||
No PCa n (%) | Indolent PCa n (%) | CSPC n (%) | Total | |
Asian-American | ||||
No PCa | 62 (79) | 3 (4) | 8 (10) | 73 |
Indolent PCa | 0 (0) | 0 (0) | 0 (0) | 0 |
CSPC | 0 (0) | 1 (1) | 4 (5) | 5 |
Total | 62 | 4 | 12 | 78 |
Other | ||||
No PCa | 239 (51) | 45 (10) | 101 (22) | 385 |
Indolent PCa | 12 (3) | 13 (3) | 8 (2) | 33 |
CSPC | 2 (0) | 5 (1) | 41 (9) | 48 |
Total | 253 | 63 | 150 | 466 |
CSPC, clinically significant prostate cancer; PCa, prostate cancer.